170 related articles for article (PubMed ID: 1354232)
1. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
[TBL] [Abstract][Full Text] [Related]
2. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
3. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
4. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
5. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of arachidonate and paf-acether precursor pools in mast cells.
Joly F; Breton M; Wolf C; Ninio E; Colard O
Biochim Biophys Acta; 1992 May; 1125(3):305-12. PubMed ID: 1596519
[TBL] [Abstract][Full Text] [Related]
10. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
11. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
Malone B; Lee T; Snyder F
J Biol Chem; 1985 Feb; 260(3):1531-4. PubMed ID: 3918041
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of paf-acether: VIII: Impairment of paf-acether production in activated macrophages does not depend upon acetyltransferase activity.
Roubin R; Dulioust A; Haye-Legrand I; Ninio E; Benveniste J
J Immunol; 1986 Mar; 136(5):1796-802. PubMed ID: 3950403
[TBL] [Abstract][Full Text] [Related]
14. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
15. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
16. Phorbol diester enhances calcium ionophore A23187-induced [3H]acetate incorporation into platelet-activating factor in murine macrophages: predominant incorporation into 1-O-acyl-2-acetyl-sn-glycero-3-phosphocholine.
Wey HE
J Cell Biochem; 1989 Mar; 39(3):305-13. PubMed ID: 2496135
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.
Vivier E; Salem P; Dulioust A; Praseuth D; Metezeau P; Benveniste J; Thomas Y
Eur J Immunol; 1988 Mar; 18(3):425-30. PubMed ID: 2895712
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor stimulates phosphatidic acid formation in cultured rat mesangial cells: roles of phospholipase D, diglyceride kinase, and de novo phospholipid synthesis.
Kester M
J Cell Physiol; 1993 Aug; 156(2):317-25. PubMed ID: 8393878
[TBL] [Abstract][Full Text] [Related]
19. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.
Triggiani M; Fonteh AN; Chilton FH
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):497-503. PubMed ID: 1530582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]